Research Article
Comparison of Treatment Approaches and Subsequent Outcomes within a Pulmonary Embolism Response Team Registry
Table 1
Patient characteristics and outcomes by primary outcome (treatment approach).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The percentages within each cell were calculated using the N in the column header for that cell (e.g., of all patients who received anticoagulation monotherapy, 53/1440 (3.7%) were classified as high-risk PE at ED presentation. Conversely, all 139 (38.1%) high-risk PE patients in this study had anticoagulation monotherapy). †We found the following proportions for each criterion used to determine PE severity: 81% had a RV : LV ratio of 1.0 or greater as determined by CT, 22% had RV dilatation by echocardiography, 3.2% arrived in cardiac arrest, 5.0% required vasopressor support at presentation, 5.6% had sustained hypotension, 5.2% had episodic hypotension, 17.8% had a sustained elevated shock index, 36.2% had hypoxia with respiratory distress at rest, 68% had elevated troponin, and 57.2% had elevated brain natriuretic peptide levels. |